Market revenue in 2023 | USD 578.3 million |
Market revenue in 2030 | USD 898.7 million |
Growth rate | 6.5% (CAGR from 2023 to 2030) |
Largest segment | Proteases |
Fastest growing segment | Proteases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteases |
Key market players worldwide | Biocatalysts Ltd, Merck KGaA, Codexis Inc, Roche Holding AG, Amano Enzyme, Advanced Enzymes, Amicogen, Dyadic International Inc, BBI Solutions, Affymetrix, American Laboratories, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in-vitro diagnostics enzymes market will help companies and investors design strategic landscapes.
Proteases was the largest segment with a revenue share of 100% in 2024. Horizon Databook has segmented the Europe in-vitro diagnostics enzymes market based on proteases covering the revenue growth of each sub-segment from 2018 to 2030.
The presence of a well-established IVD market in many European countries including Germany, France, the UK, Italy, & Spain is one of the key factors for increased adoption and demand for IVD enzymes in the region.
According to the German Diagnostics Industry Association (VDGH), Germany accounts for the largest IVD market in Europe. VDGH also states that Germany is home to more than 150 manufacturers of reagents and systems for IVD use and 74% of the German diagnostics companies conduct R&D & manufacturing within the country.
The European Diagnostic Manufacturers Association (EDMA) reports that molecular diagnostics accounts for the fastest-growing IVD industries in Europe owing to the rise in penetration of techniques such as real-time PCR and next-generation sequencing that facilitate the decoding and amplification of epigenetic & genetic information.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe in-vitro diagnostics enzymes market, including forecasts for subscribers. This continent databook contains high-level insights into Europe in-vitro diagnostics enzymes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account